Sonoma Pharmaceuticals terminates COO ‘for cause’
Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA), a Boulder-based company that develops wound-care and dermatology products, has terminated its chief operating officer.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Transformative Biotech LLC, a Boulder molecular diagnostics technology startup company, recently hired Barbara Handelin as…
-
Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA) reported record revenue and a lower net loss for the…
-
Enliven Therapeutics Inc. (Nasdaq: ELVN), a clinical-stage precision oncology company, has appointed physician Lori Kunkel…
-
Edgewise Therapeutics Inc. (Nasdaq: EWTX) has promoted Behrad Derakhshan, formerly the Boulder-based muscle disease biopharmaceutical…
